These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4064304)

  • 61. The absence of hemolytic disease in the newborn rhesus monkey (Macaca mulatta).
    Stong RC; Houser WD; Stone WH
    Vet Immunol Immunopathol; 1982 Nov; 3(6):611-27. PubMed ID: 6891138
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Clinical analysis of seven cases of rare hemolytic disease of the newborn].
    Gu S; Wang HX; Yang CY; Yang XF; Lin Y; Zhong Y; He JP; Wang YJ
    Zhonghua Er Ke Za Zhi; 2018 May; 56(5):369-372. PubMed ID: 29783824
    [No Abstract]   [Full Text] [Related]  

  • 63. Prediction of fetal blood group and platelet antigens from maternal plasma using next-generation sequencing.
    Orzińska A; Guz K; Mikula M; Kluska A; Balabas A; Ostrowski J; Uhrynowska M; Kopeć I; Dębska M; Luterek K; Brojer E
    Transfusion; 2019 Mar; 59(3):1102-1107. PubMed ID: 30620409
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hemolytic disease of the fetus and newborn due to anti-Ge3: combined antibody-dependent hemolysis and erythroid precursor cell growth inhibition.
    Blackall DP; Pesek GD; Montgomery MM; Oza KK; Arndt PA; Garratty G; Shahcheraghi A; Denomme GA
    Am J Perinatol; 2008 Oct; 25(9):541-5. PubMed ID: 18720327
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evaluation of antisera for bloodstain grouping. II. Ss, Kell, Duffy, Kidd, and Gm/Km.
    Gaensslen RE; Lee HC; Pagliaro EM; Bremser JK; Carroll-Reho J
    J Forensic Sci; 1985 Jul; 30(3):655-76. PubMed ID: 4031801
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Study of red blood cell alloimmunization risk factors in multiply transfused thalassemia patients: role in improving thalassemia transfusion practice in Fayoum, Egypt.
    Abdelrazik AM; Elshafie SM; El Said MN; Ezzat Ahmed GM; Al-Gamil AK; El Nahhas MG; Sady AA
    Transfusion; 2016 Sep; 56(9):2303-7. PubMed ID: 27351342
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Presence of anti-Yta antibody in a Yt(a+) patient.
    Mazzi G; Raineri A; Santarossa L; De Roia D; Orazi BM
    Vox Sang; 1994; 66(2):130-2. PubMed ID: 8184594
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Hemolytic disease of the newborn due to Kell sensitization].
    Beller U; Hochner-Celnikier D; Ron M; Palti Z; Beyth Y
    Harefuah; 1981 Jul; 101(1-2):14-5. PubMed ID: 7319365
    [No Abstract]   [Full Text] [Related]  

  • 69. The diagnosis of ABO haemolytic disease.
    Dunning EK
    Vox Sang; 1968; 14(6):409-16. PubMed ID: 4971967
    [No Abstract]   [Full Text] [Related]  

  • 70. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Unusual Duffy system antibodies in a female patient with a blood transfusion complication].
    Umnova MA; Skachilova NN; Piskunova TM; Ichalovskaia TA; Oshkina NP
    Probl Gematol Pereliv Krovi; 1977 Dec; 22(12):38-40. PubMed ID: 600940
    [No Abstract]   [Full Text] [Related]  

  • 72. Expression of blood group antigens on red cell microvesicles.
    Oreskovic RT; Dumaswala UJ; Greenwalt TJ
    Transfusion; 1992; 32(9):848-9. PubMed ID: 1281942
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Kell sensitization in pregnancy.
    Caine ME; Mueller-Heubach E
    Am J Obstet Gynecol; 1986 Jan; 154(1):85-90. PubMed ID: 3946507
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Does anti-Jra cause hemolytic disease of the newborn?
    Toy P; Reid M; Lewis T; Ellisor S; Avoy DR
    Vox Sang; 1981; 41(1):40-4. PubMed ID: 7324442
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Duffy blood groups and their antibodies (anti Fya antibody, anti FyB antibody)].
    Kitamura K
    Nihon Rinsho; 1999 Nov; 57 Suppl():610-1. PubMed ID: 10635925
    [No Abstract]   [Full Text] [Related]  

  • 76. INFLUENCE OF FOETAL A AND B BLOOD-GROUP SUBSTANCES ON THE IMMUNIZATION OF PREGNANT WOMEN.
    HOSTRUP H
    Vox Sang; 1964; 9():301-14. PubMed ID: 14170900
    [No Abstract]   [Full Text] [Related]  

  • 77. [Haemolytic disease of the new-born by blood-factor incompatibility other than Rh(d) and ABO (author's transl)].
    Schellong G; Sandmann G; Fischer K; Poschmann A
    Dtsch Med Wochenschr; 1976 Oct; 101(44):1591-7. PubMed ID: 824115
    [TBL] [Abstract][Full Text] [Related]  

  • 78. HEMOLYTIC DISEASE OF THE NEWBORN CAUSED BY ANTI-JK.
    GECZY A; MATHESON WA
    Am J Obstet Gynecol; 1965 Jun; 92():576-7. PubMed ID: 14295897
    [No Abstract]   [Full Text] [Related]  

  • 79. Anti-M antibody developed during pregnancy.
    Melartin L; Kaarsalo E
    Scand J Haematol; 1965; 2(3):183-6. PubMed ID: 5834400
    [No Abstract]   [Full Text] [Related]  

  • 80. Practical application of the Rh factor in congenital hemolytic anemia of the newborn (erythroblastosis fetalis), habitual abortion, and blood transfusions.
    HAYMOND JL; GIORDANO AS
    J Indiana State Med Assoc; 1946 Sep; 39():429-35. PubMed ID: 20996186
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.